Tetrahedral DNA Nanostructures as a Multifactorial Nanotherapeutic Platform for Deep Vein Thrombosis: Targeting Necroptosis, Oxidative Stress, and Inflammation.

Int J Nanomedicine · 2025 · PMC12640153 · PMID 41281250

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

34 In the present study, although TDN treatment significantly downregulated the expression of key regulators such as RIP3, MLKL, PTPRC, and CCR9, the change in TNFSF8 expression did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.